Gruppenleiter
Prof. Dr. med. Evelin Schröck
Prof. Dr. med., Fachärztin für Humangenetik
Direktorin Institut für Klinische Genetik
Co-Direktorin Core Unit für Molekulare Tumordiagnostik (CMTD)
am NCT/UCC Partnerstandort Dresden
Haus 137, Etage 2
0351 458-15136
E-Mail
Academic Research and clinical appointments
| 2021 - | Head, Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the TU Dresden, Germany |
| 2015 - | Task Force Coordiniator, Task Force Molecular Stratification, Nationales Centrum für Tumorerkrankungen, NCT-Partnerstandort Dresden, Germany |
| 2015 - | Director, Molecular Tumor Diagnostic Center, Nationales Centrum für Tumorerkrankungen, NCT-Partnerstandort Dresden, Germany |
| 2015 - | Member of the Direktorium Nationales Centrum für Tumorerkrankungen, NCT- Partnerstandort Dresden, Germany |
| 2003 - 2020 | Head, Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany |
| 2001 - 2003 | Head, Tumorcytogenetic Diagnostics and Principal investigator, Tumor Genetics and Molecular Cytogenetics, Institute of Medical Genetics, Humboldt-University, Charité, Berlin, Germany |
| 1999 - 2001 | Principal Investigator, Tumor Genetics and Molecular Cytogenetics, Institute for Molecular Biotechnology (IMB), Jena, Germany |
| 1999 | Habilitation: "Spectral karyotyping and comparative genomic hybridization - new methods for the comprehensive analysis of chromosomal aberrrations in clinical diagnostics and tumor genetics", National Cancer Institute (Dr. Thomas Ried) and Institute of Medical Genetics , Humboldt-University of Berlin (Prof. Dr. Regine Witkowski) |
| 1998 - 1999 | Staff Scientist (permanent), Section of Fluorescence In Situ Hybridization Techniques (Dr. Thomas Ried), Genetics Department, National Cancer Institute/National Institutes of Health, Bethesda, MD |
| 1996 - 1998 | Visiting Scientist, Section of Fluorescence In Situ Hybridization Techniques (Dr. Thomas Ried), Genetics Department, National Cancer Institute/National Institutes of Health, Bethesda, MD |
| 1994 - 1996 | Special Volunteer, Section of Fluorescence In Situ Hybridization Techniques (Dr. Thomas Ried), Diagnostic Development Branch/National Center for Human Genome Research/National Institutes of Health, Bethesda, MD |
| 1992 | Thesis "Database structure for phenotype diagnostics", Institute of Medical Genetics, Humboldt-University of Berlin, Germany (Prof. Dr. Regine Witkowski) |
| 1991 - 1994 | Research Assistant, Institute of Human Genetics, University of Heidelberg, Section of Molecular Cytogenetics (Prof. Dr. Thomas Cremer) |
| 1991 | Board Certification "Facharzt für Humangenetik", Institute of Medical Genetics, Humboldt-University of Berlin, Germany (Prof. Dr. Regine Witkowski) |
| 1987 - 1991 | Medical Assistant at the Institute of Medical Genetics, Humboldt-University of Berlin (Prof. Dr. Regine Witkowski) |
| 1980 - 1986 | Medical Faculty "Charité, Humoldt-University of Berlin, Germany |
Awards
| 1994 - 1996 | DFG Research Fellowship |
| 1997 | Scientific Award of the German Society of Human Genetics |
| 2000 | BioFuture Award of the Federal Ministry of Education and Research (BMBF), 3,9 Mio DM |
National and International Societies and Committees
| 2021 - | "German Society of Human Genetics" (GfH), Vice Chairwoman and Member of the Executive Board |
| 2014 - | Luxembourg Institute of Health (LIH), Luxembourg, Board of Administration |
| 2013 - 2014 | CRP-Santé, Luxembourg, Board of Administration |
| 2012 -2014 | Past President and Board Member "International Society of Cellular Oncology" (ISCO) |
| 2010 - 2012 | President "International Society of Cellular Oncology" (ISCO) |
| 2009 - 2015 | Member of the genetic diagnostics commission of the Federal Ministry of Health at the Robert Koch Institute in Berlin, Germany |
| 2009 - | Member of the expert committee "Klinische Forschung / kliniknahe Grundlagenforschung" Deutsche Krebshilfe |
| 2008 - | German Society for Human Genetics (GfH), Chairperson of the commission "Diagnosebezogene Abrechnungsmodelle" |
| 2008 - 2010 | Board Member and President elect., International Society of Cellular Oncology (ISCO) |
| 2008 - 2010 | Berufsverband Deutscher Humangenetiker (BSDH), Spokesperson for university specialists and member of the board of directors |
| 2008 - 2010 | German Society for Human Genetics (GfH), Vice Chairwoman and Member of the Executive Board, Chairwoman of the commission for the establishment of indication criteria for the introduction of molecular karyotyping by means of microarray analyses into human genetic diagnostics. |
| 2006 - 2008 | German Society for Human Genetics (GfH), Treasurer and Member of the Board |